Article
IDH1, ATRX, and BRAFV600E mutation in astrocytic tumors and their significance in patient outcome in north Indian population
1 Jan 2018
Abstract excerpt
Background: According to the current World Health Organization (WHO) classification of central nervous system (CNS) tumors ( This study was carried out to determine the frequency of isocitrate dehydrogenase 1 (IDH1), ATRX, and BRAF V600E mutations in different grade astrocytomas and their prognostic value. Methods: Eighty cases of astrocytoma (15 pilocytic astrocytoma, 25 diffuse astrocytoma, 15 anaplastic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
